DB05834ExperimentalSmall molecule
OC-1012 is a compound which has emerged as a promising therapeutic agent for the treatment and prevention of mucositis, a serious side effect of chemotherapy and head and neck radiation...
- Primary indication
- Investigated for use/treatment in adverse effects (chemotherapy) and head and neck cancer.Curator reviewed
- Code names
- OC-1012
Which companies are running trials of OC-1012, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account